FDA Approved: RANITIDINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved an original ANDA for ranitidine from Rising Pharma Holdings, Inc., enabling the marketing of a generic ranitidine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Dyspepsia
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Ranitidine (Ranitidine)

Snippet

ORIG AP for RANITIDINE (RANITIDINE)